OncologyTube Professional - Patients Click Here
252,976 video views
moasc: Videos
61:00
Ricky Newton, CPA Director of Financial Services & Operations for Community Oncology Alliance describes the COAnalyzer Tool.
by:moasc | 19 views
01:04
John P. Fruehauf, MD, UC Irvine Health, Looks at Data from Combination Studies | ASCO 2019 Will Show The Role of New Combinations at MOASC 2018
by:moasc | 107 views
00:38
Fa-Chyi Lee, MD, UC Irvine Health, talks about Adjuvant Chemotherapy for Rectal Cancer | Possibly Use Single-Agent Capecitabine at MOASC 2018
by:moasc | 88 views
01:18
Edward L. Nelson, MD, UC Irvine Health talks about hoe RET Inhibitors May Be Approved this Year | Systems-Based Approach to Molecular Derangements at MOASC 2018
by:moasc | 86 views
01:19
Yung Lyou, MD, UC Irvine Health, talks about Keynote 61 Trial | See if Pembrolizumab Can be Moved to the 2nd-line Setting at MOASC 2018
by:moasc | 89 views
02:31
John P. Fruehauf, MD, UC Irvine Health, explains New Treatment for Melanoma is Working Everywhere | Working For Metastatic Disease in Brain and Body at MOASC 2018
by:moasc | 100 views
01:23
Nataliya Mar, MD, UC Irvine Health, talks about Emerging New Agents for Urothelial Carcinoma | Immunotherapies in Metastatic Castration-Resi​stant Patients at MOASC 2018
by:moasc | 43 views
01:11
John P. Fruehauf, MD, UC Irvine Health, Looks at Combinations of Therapies | Combine Targeted BRAF Agents with Immunotherapy at MOASC 2018
by:moasc | 13 views
01:01
Fa-Chyi Lee, MD, UC Irvine Health, talks about a possible Better Approach in the Next 1-2 Years | For RAS or BRAF Mutated Colorectal Cancer at MOASC 2018
by:moasc | 30 views
01:12
Edward L. Nelson, MD, UC Irvine Health talk about PI3-Kinase Inhibitors Do Not Work in Tumor Agnostic Way | Targeted Therapeutics Toward HER2 Do Not Always Work at MOASC 2018
by:moasc | 10 views
dsfsd